Search

Showing "11155" results for ""

Kivexa downgraded to alternative status in revised US HIV treatment guidelines

Why are gay men reluctant to test for HIV?

Modern HIV treatment can work well with adherence below 95%

Adenovirus-based T-cell vaccine prevents AIDS in monkeys, offering fresh hope for approach

South African resistance survey confirms that clade C is more likely to develop multi-drug resistance mutation

Treatment breaks set for a come-back?

Almost half of Africans with HIV in UK are diagnosed late

Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’

HIV treatment safe and effective in South African patients with hepatitis B co-infection, but co-infection frequent

One in five Kenyan patients suffers major interactions with HIV drugs

If you can't switch, better to stay on failing treatment than stop it, studies show

One in five Kenyan patients suffers major interactions between HIV drugs and other medicines

Second-line combinations fail twice as often as first-line ones in the first year

Once-a-day etravirine should work as first-line treatment

IL-2 provides quick ‘AIDS rescue’, but effect does not always last

Study explores verbal and non-verbal communication in unprotected sex between men

High rate of death amongst patients with HIV diagnosed late

CD4 cell count increases sustained up to five years in developing-world treatment programmes

Receive the latest HIV research and conference news

Showing "11155" results for ""

Kivexa downgraded to alternative status in revised US HIV treatment guidelines

Why are gay men reluctant to test for HIV?

Modern HIV treatment can work well with adherence below 95%

Adenovirus-based T-cell vaccine prevents AIDS in monkeys, offering fresh hope for approach

South African resistance survey confirms that clade C is more likely to develop multi-drug resistance mutation

Treatment breaks set for a come-back?

Almost half of Africans with HIV in UK are diagnosed late

Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’

HIV treatment safe and effective in South African patients with hepatitis B co-infection, but co-infection frequent

One in five Kenyan patients suffers major interactions with HIV drugs

If you can't switch, better to stay on failing treatment than stop it, studies show

One in five Kenyan patients suffers major interactions between HIV drugs and other medicines

Second-line combinations fail twice as often as first-line ones in the first year

Once-a-day etravirine should work as first-line treatment

IL-2 provides quick ‘AIDS rescue’, but effect does not always last

Study explores verbal and non-verbal communication in unprotected sex between men

High rate of death amongst patients with HIV diagnosed late

CD4 cell count increases sustained up to five years in developing-world treatment programmes

Receive the latest HIV research and conference news